Speaker information will be added as speakers are confirmed. Please check this page regularly for updated information.  

Click on the letter below to navigate by speaker’s last name.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sarah Aguayo, Hospital Base San José Osorno, Osorno, Chile

Sara Aguayo is the Pharmacist in charge of the central admixture of oncological drugs of the Hospital base San José de Osorno. She graduated has a Pharmacist from the Universidad de Concepción on 2006. Since then she has dedicated to the oncology pharmacy. She has a Master degree on Pharmaceutical Oncology by the Universidad de Valencia and others post graduates degrees in palliative care and health administration. She is member of the Chilean chapter of Oncology pharmacist since 2007 and active member of the oncology committee of the hospital. Sara has gained practical experience in adult oncology patient. 
 

Milan J. Anadkat, Washington University School of Medicine, St. Louis, MO, USA

Dr. Milan Anadkat is an Associate Professor of Dermatology and Residency Program Director at Washington University School of Medicine. He graduated from the University of Akron and earned his medical degree at the Northeastern Ohio Universities College of Medicine.  Dr. Anadkat performed his residency training at Washington University School of Medicine in St. Louis. He also completed a two-year clinical trials fellowship at Washington University School of Medicine. 

In 2007, Dr. Anadkat joined the faculty of Washington University School of Medicine in St. Louis, MO.  His clinical focus is in the area of complex medical dermatology, with a unique interest in oncodermatology. He is a national leader in the field of dermatologic therapeutics, graft-versus-host disease, and most notably, chemotherapy-induced adverse reactions. He has numerous publications and been invited to deliver many lectures on these topics.

Dr. Anadkat is a member of the American Academy of Dermatology, Medical Dermatology Society, American Professors of Dermatology, Society of Investigative Dermatology, and MASCC (Multinational Association of Supportive Care in Cancer). He has served on Work Groups and Task Forces for the American Academy of Dermatology, National Cancer Institute, MASCC, and NCCN. He is also on the Editorial Board for the Journal of Supportive Care in Cancer and Journal of the American Academy of Dermatology Case Reports.

Tiene Bauters, Ghent University Hospital, Ghent, Belgium

Tiene Bauters is a clinical pharmacist at the Ghent University Hospital (Belgium) since 2003. She earned her Doctor of Pharmacy degree from the Ghent University. For almost 10 years, she’s involved in Pediatric Hematology, Oncology and Stem Cell Transplantation. In this role, she provides clinical pharmacy services with focus on supportive care. She’s author of numerous peer-reviewed publications on topics related to pediatric oncology and presented at many international conferences. She’s an ISOPP member since 2008 and serves as general secretary member since 2014. Tiene Bauters is currently member of ISOPP, SIOP, ASBMT. She’s the European pharmacist’s representative for FACT-JACIE standards.

Christian Caglevic, Fundación Arturo López Pérez, Santiago, Chile

Christian Caglevic is a Medical Oncologist graduated at Universidad de Chile, Postgrade in Molecular Oncology and Targeted Therapies at Universidad del Salvador, Buenos Aires, Argentina. Currently, he is Medical Oncologist at Fundación Arturo López Pérez of Santiago, Chile and Head of the Early Development of Drugs Unit at the same institution. Dr. Caglevic has been principal investigator and sub investigator in several clinical trials in solid tumors. He has several publications in solid tumors treatment but also in basic sciences. He participates in ASCO as collaborative member and is also member of ESMO, ILOGI, Sociedad Médica de Chile, IASLC, SIOG, Sociedad Chilena de Oncología Médica, Grupo Latinoamericano de Tumores Gastrointestinales. Dr Caglevic is Board Member of Ecancer Medical Science and recently reviewer of several journals as Oncotarget and Revista Médica de Chile. He was the past Director of the Latin American Symposium of Gastroenterological Cancer (SLAGO), current leader of the Latin American Consensus in Pancreatic Cancer. 

Carole R. Chambers, Tom Baker Cancer Clinic Pharmacy, Calgary, Alberta, Canada

Carole Chambers is the Pharmacy Director of Cancer Services with the Alberta Health Services, with over 50 peer reviewed publications. She currently serves on the provincial advisory group for pCODR and the panCanadian pricing negotiating teams dealing with access issues to new oncology agents. She also joined the Board of the Institute of Safe Medication Practice (ISMP-Canada) .Carole has remained active in ISOPP since completing her term as ISOPP President in 2010 as she sits on the JOPP Editorial Board, served on the Scientific Committee for ISOPP in Montreal 2014,  and is a member of the team generating the ISOPP virtual journal club. She holds an ISOPP Fellowship as well as the Helen McKinnon award recognizing her significant contribution to ISOPP and oncology pharmacy practice.

Alexandre Chan, National University of Singapore, Singapore

Alexandre Chan, Pharm.D., MPH, FCCP, BCPS, BCOP is a Deputy Head and a tenured Associate Professor at Department of Pharmacy, Faculty of Science at National University of Singa­pore (NUS) and Duke-NUS Medical School. He is also appointed as an adjunct faculty at University of California, San Francisco School of Pharmacy and University of the Pacif­ic Thomas J. Long School of Pharmacy and Health Sciences. He is also a pro­gram director for the National Oncol­ogy Pharmacy Residency Program in Singapore. Currently, he is dually board certified in Pharma­cotherapy and Oncology Pharmacy. Dr. Chan has published over 120 full-length peer-re­viewed manuscripts in a wide array of cancer supportive care topics, including chemotherapy-induced nausea and vomiting, myelosuppression, cognitive impair­ment, dermatological toxicities and cancer-related fatigue. He was the recipient of the Young Scientist Award from National University of Singapore in 2013, and he was elected as an American College of Clinical Pharmacy (ACCP) Fellow in 2014. He was also the recipient of the Steven M. Grunberg Memorial Award from Multinational Association of Supportive Care in Cancer in 2015. 

Mario Chiong Lay, University of Chile and Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile

Dr. Mario Chiong is Associate Professor at the Department of Biochemistry and Molecular Biology at the Faculty of Chemical and Pharmaceutical Sciences, University of Chile. Beside its academic activities Dr. Chiong is also an Associate Investigator in the Advanced Center for Chronic Diseases (ACCDiS). This Center is a multidisciplinary research initiative that study the natural history of cardiovascular diseases and cancer in the Chilean population. He directs a laboratory of six graduate students/postdoctoral fellows and one technician. He began to work in pharmacogenomics more than a decade ago studying drug efficacy and adverse effects in patients with heart failure. Actually Dr. Chiong has more than 100 papers published in ISI-ranked journals and 6 patents.

Dr Chiong is a Biochemist (University of Chile) and received a PhD in Pharmacology (University of Chile). In the area of Pharmacology, he has performed Research Training in the National Institute of Biological Standards and Control (UK) and in the Food and Drug Administration (USA). He is professor in the careers of Pharmaceutical Chemist, Biochemistry and Medicine and in the MSc and PhD programs of Biochemistry, Pharmacology, Pharmaceutical Science, and Biomedical Science, at University of Chile.

Alejandro Corvalan, Pontificia Universidad Catolica de Chile, Santiago, Chile

Full-time medical researcher at Pontificia Universidad Catolica de Chile, involved in translational cancer research at basic, clinical and population levels. My research is primarily focused on cancer epigenetics with an emphasis on the discovery and validation of tumor suppressor genes inactivated by DNA methylation. These discoveries act as potential biomarkers for the early diagnosis of cancer, monitoring treatment response and developing new treatments. Through this research, I'm developing a novel screening and triage test for the early detection of gastric cancer based on cell free DNA in plasma. I'm also investigating the role of two p53-dependant tumor suppresor genes, Reprimo and p73, in the pathogenesis of gastric cancer. In addition to this I have a strong interest in genomics, specifically exploring cancer heterogeneity through a data-mining approach by using existing databases and open-source / in-house bioinformatic softwares. 

Back to Top

Harbans Dhillon, University Malaya Medical Centre, Kuala Lumpur, Malaysia

Harbans started working as a manufacturing pharmacist in University Malaya Medical Centre in 1978. She was appointed as Chief Pharmacist in April 2015 and then promoted to Deputy Director (Professional) in September 2015.

Harbans was the President of PENSMA (Parenteral and Enteral Nutrition Society of Malaysia) 1998-2010. She was president of PENSA (Parenteral and Enteral Nutrition Society of Asia) 2007-2009. Currently she is an advisor to both societies.

Harbans is the president-elect of ISOPP and was on the secretariat 2007-2009. She was also the President of Asia4safehandling Organisation which promotes safe handling of cytotoxic drugs in Asia 2009-2010 and is still a board member. 

Gustavo Espinoza, Central de preparaciones oncológicas REDSANA, Santiago, Chile

Gustavo Espinoza, since 2009, is the pharmacist in charge of the manufacturing process supervision inside the central of oncological admixture, belonging to the highly specialized pharmacy RedSana S.A. He earned his pharmacist degree from the Universidad de Chile and for more than 8 years he has been developing his career in several aspects of the oncology specialty. Nowadays, his main role is to guarantee the quality of the oncological admixtures that are distributed through different medical centers across the country. He has participated as a speaker in different symposiums and congress such as SLAURO, SLAGO, Chilean Congress of Cancerology and the Chilean Congress of Mastology, spreading scientific information concerning to the oncology pharmacy practice. Gustavo Espinoza is currently member of the Chapter of Chilean Oncology Pharmacists and he is responsible for the communications and social Medias of the society, promoting and collaborating in the organization of workshops and conferences in oncology pharmacy throughout Chile.
 

Martha Estacio, Instituto Nacional de Enfermedades Neoplasicas Eduardo Caceres Graziani, Lima, Peru

Martha Estacio  is a clinical pharmacist of the  Instituto Nacional de Enfermedades Neoplasicas Eduardo Caceres Graziani. She graduated from the Universidad Nacional Mayor de San Marcos and she has obtained postgraduate studies in clinical pharmacy. She was dedicated  for six  years to preparation  Parenteral Nutrition, then pharmacist in charge of the manufacturing process supervision inside the central of oncological admixture and  nowadays responsible for the development of Pharmacovigilance and Clinical Pharmacy unit at the  Instituto Nacional de Enfermedades Neoplasicas Eduardo Caceres Graziani .  Also, she is an associate professor of the Universidad Particular Norbert Wiener, teaching classes of pharmacotherapy. As well, she is a member of scientific societies such as the Asociacion Peruana de Terapia Nutricional, participating as a speaker in the areas of oncology and parenteral nutrition.

Ivonne Flores, Fundación Arturo López Pérez, Santiago, Chile

Ivonne Flores is a clinical pharmacist of the Instituto Oncológico Fundación Arturo López Pérez. She graduated from the Universidad de Chile and she has obtained postgraduate studies in hospital and clinical pharmacy. Since then she has dedicated herself professionally to the oncology pharmacy, initially in the preparation of the cytotoxic drugs and later responsible for the development of Pharmacovigilance and Clinical Pharmacy Program in the Fundación Arturo López Pérez, developing her work in the clinical services Ambulatory Chemotherapy, Medicine, Surgery and Intensive Care Unit. Also, she is an associate professor of the Universidad San Sebastian, teaching classes of oncology clinical pharmacy and is a professor guide of internship pharmacy students. As well, she is a member of scientific societies such as the Society of Hospital Pharmacy and the Chilean Society of Intensive Medicine, participating as a speaker and in the organization of congresses, both in the areas of oncology and critical medicine.

Peter Gilbar, Toowoomba Hospital, Toowoomba, Australia

Peter Gilbar is a Pharmacist Consultant – Cancer and Palliative Care Services and Senior Lecturer – School of Medicine, University of Queensland at Toowoomba Hospital, Australia. He holds a Bachelor of Pharmacy from the University of Queensland, a Masters in Palliative Care from Flinders University, and Fellowships from the Society of Hospital Pharmacists of Australia (SHPA) and International Society of Oncology Pharmacy Practitioners (ISOPP).  He serves on the Editorial Board of the Journal of Oncology Pharmacy Practice and Journal of Pediatric Oncology, and is a member of the ISOPP Education and Membership Committees. Santiago is the 12^th ISOPP Symposia he has attended. Peter is a regular contributor to peer reviewed journals (over 60 publications) and presenter at oncology conferences. His particular areas of interest and research include medication safety, symptom management and rural oncology practice.

Jorge Gallardo, Clínica Alemana de Santiago, Instituto de Terapias Oncológicas Providencia, Santiago, Chile

Jorge Gallardo E. was born in the city of Coquimbo, Chile, and studied medicine at the University of Concepción. He studied Internal Medicine and did his specialization in Medical Oncology Faculty of Medicine and Clinical Hospital of the University of Chile. Jorge studied improvement, specialization in oncology, hematology and bone marrow transplantation in Germany. He also was awarded with a scholarship for a course of "Improvement in oncology clinic”, in the United States. Jorge is a medical oncologist and clinical work is done in a private health institution in patients with solid tumors, especially tumors GI. He is also President of Chile Cancer Foundation which is the organized of the Symposium Latinoamericano de Gastroenterologia Oncológica (SLAGO). 

Barry Goldspiel, National Institutes of Health Clinical Center, Bethesda, MD, USA​

Claudio González, Unidad Oncología Hospital pediátrico Exequiel González Cortés, Santiago, Chile

Claudio González Muñoz is a Clinical Pharmacist at the  Exequiel González Cortes Hospital (EGCH). EGCH is an important Pediatric Hospital located in Santiago, Chile. Claudio was graduated from The Pontifical Catholic University of Chile (PUC) and has a diplomate in Clinical investigation and a diplomate in Clinical Studies from University of Chile. Claudio is the responsible of the Clinical Pharmacy Unit, specifically in the oncology and intensive care unit. He takes part in the daily clinical visit with oncology, Infectious Disease, intensive care and pediatric specialists to reach the rational use of medicines. His main lines of scientific research are antimicrobial pharmacokinetic and pharmacovigilance. Currently he is member of the American Collegue of Clinical Pharmacy (ACCP), Clinical Pharmacist Division of Chilean Intensive Medicine Society (SOCHIMI) and the Sociedad Chilena de Farmacia Asistencial (SCHFA). 

Evelyn Handel, National Comprehensive Cancer Network (NCCN), Ambler, PA, USA

Evelyn Handel, PharmD, BCPS, BCOP is currently an Oncology Scientist at the National Comprehensive Cancer Network® (NCCN®) where she helps develop and maintain the NCCN Drugs & Biologics Compendium® and NCCN Chemotherapy Order Templates®, among other projects. Prior to joining NCCN, Dr. Handel was an Oncology Clinical Pharmacist Specialist at Roswell Park Cancer Institute working with the inpatient and outpatient solid tumor services. In this role, she provided chemotherapy-related patient counseling as well as side effect management through a collaborative drug therapy management (CDTM) program, helped create a pharmacist-led oral chemotherapy monitoring program, and precepted pharmacy students and residents. She also served as adjunct clinical faculty for both D’Youville College of Pharmacy and the University at Buffalo School of Pharmacy. She earned her Doctor of Pharmacy from Ohio Northern University and completed a PGY1 Pharmacy Practice Residency at Oregon Health & Science University Hospital followed by a PGY2 Oncology Pharmacy Residency at the H. Lee Moffitt Cancer Center. 

R. Donald Harvey, Winship Cancer Institute of Emory University, Atlanta, GA, USA

R. Donald Harvey, PharmD, FCCP, BCOP is Associate Professor of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, and serves as director of the Winship Cancer Institute’s Phase I Clinical Trials Unit and Section. He has established an active clinical pharmacology research program in cancer at Emory with the goal of using pharmacokinetic, pharmacodynamic, and other tools to improve individualization of therapy and clinical outcomes.  

Back to Top

Kellie Jones Weddle, Purdue University, Indianapolis, IN, USA

Kellie Jones Weddle, BCOP, FCCP is Clinical Professor of Pharmacy Practice, College of Pharmacy, Purdue University and Adjunct Assistant Professor of Medicine, Department of Medicine, Indiana University School of Medicine. She received her B.S. (Pharmacy) and PharmD from the University of Kentucky. Dr. Weddle also completed Pharmacy Practice and Oncology Specialty residencies at the University of Kentucky. She is a board certified oncology pharmacist. She has worked as an Oncology Clinical Specialist at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. During her seven years there, her primary focus was in breast and gynecologic malignancies. In September, 2007, Dr. Weddle joined the faculty at Purdue University. Her clinical practice site is at Indiana University Simon Cancer Center working with the medical and gynecologic oncology services. 

Tara Leslie, Tom Baker Cancer Centre and University of Alberta, Calgary, AB, Canada

Tara Leslie attained her Bachelor of Science in Pharmacy (BSP) degree from the University of Saskatchewan in 1997, obtained her Board Certification in Oncology Pharmacy (BCOP) in 2010, and acquired her Additional Prescribing Authority in 2013.  She is a Clinical Pharmacist at the Tom Baker Cancer Centre in Calgary, Canada and a Clinical Assistant Professor with Experiential Education at the Faculty of Pharmacy, University of Alberta.  For several years, Tara’s primary area of clinical practice has been with hematologic malignancy and bone marrow transplant patients.  Tara is very involved with oncology education of pharmacy students as a preceptor and as an educator on topics such as hematologic malignancy, chemotherapy safety and oncology related symptom management.  Tara is an active member of ISOPP and the Canadian Association of Pharmacy in Oncology, also known as CAPhO.  She serves as Chair for the CAPhO Pharmacist Education Committee and is Co-Chair of the CAPhO 2020 Task Force. 
 

Annemeri Livinalli, Sociedade Brasileira de Farmacêuticos em Oncologia, Sao Paulo, Brazil

Annemeri graduated as a pharmacist, has a Masters degree in pharmaceutical sciences and a postgraduate degree in health administration and clinical pharmacology. Annemeri has gained practical experience in pediatric oncology and theoretical knowledge in different areas, including geriatric oncology. She is a member of Sobrafo board (Brazilian Society of Oncology Pharmacist) since 2007, currently as director of communication.  Annemeri is also Ad-Hoc reviewer of Journal of Oncology Pharmacy Practice since 2008.

Klaus Meier, Heidekreis-Klinikum GmbH, Soltau, Germany

Klaus Meier is CEO of the Department for Clinical and Hospital Pharmacy, HKK trust Soltau, Lower Saxony. In 1975 master of theology and paedagogics. Since 1981 pharmacist, in 1989 Clinical and in 1995 Oncology certification.

Klaus Meier has developed the QuapoS (Quality standard for Oncology Pharmacy Service). 5 editions have been published since 1996 in 27 languages. 2009 he became fellow of the EACS (European Academy for Cancer Sciences) and is acting as Vicedirector at IFAHS (Institute for applied healthcare sciences).

In 1998 – 2000 he was President of ISOPP. For 4 years he was member of the board of directors of European CanCer Organisation (ECCO), and is President of the German Society for Oncology Pharmacy (DGOP) as well for the European Society for Oncology Pharmacy (ESOP) which is accreditated at EMA as HCPS (Health Care Professional Society).

Since 2007 Klaus Meier is the editor-in-chief of the EJOP (European Journal of Oncology Pharmacy).
 

Jorge Morales Vallespín, Luis Calvo Mackenna Hospital, Santiago, Chile

Clinical Pharmacist graduate from Catholic University of Chile (PUC) and training in Clinical Pharmacology and Pharmacokinetics, Master of Health Administration PUC with performance at Luis Calvo Mackenna Hospital (HLCM) since 2005. Responsible for development and implementation of the Clinical Pharmacology Program at Oncology and Bone Marrow Transplant Units since 2006. Stay Pharmaceutical Pharmacy Service Clinic, St. Jude Children's Research Hospital, Memphis, USA, 2007 and 2009:"Applications of Clinical Pharmacy and Clinical Pharmacokinetics in Pediatric Oncology." Serving as head of the unit from that date until 2015. Actually, head of hospital pharmacy at HLCM, Performance in teaching, research and training in conjunction with the Oncology Program and Bone Marrow Transplant HLCM-International Outreach St Jude Hospital, Reviewer Chilean and foreign scientific journals, scientific articles and participation in research associated with pharmacogenomic pharmacokinetics of neutropenic patients and pediatric ALL patients.

Felice Musicco, Istituti Fisioterapici Ospitalieri Regina Elena San Gallicano, Rome, Italy

Felice Musicco is the Pharmacy Director of External Hospital Pharmacy with the Istituti Fisioterapici Ospitalieri (IFO) in Rome; IFO is a public research oncological and dermatological hospital. He is also responsible of the hospital pharmacovigilance services.  Prior to joining IFO, Dr. Felice was a Military Pharmacist at "Celio" Military Hospital in Rome and at Military Hospital in Chieti.

He is currently Chair of the ISOPP Publications Committee since 2007. Is a member of the team generating the ISOPP Virtual Journal Club. He was the first administrator of the ISOPP facebook page and promoter of twitter use at ISOPP symposias. Santiago is the ^5th ISOPP Symposia he has attended.

He served as Chief of the website editorial board of the Italian Society of Hospital Pharmacists. His particular areas of interest and research include medication safety, reporting drug adverse events in both clinical and experimental setting. Other area of interest is information technology applied to pharmaceutical care (relational databases, mobile technology, web editing, social media and Internet).

Shaun O'Connor, Eastern Health, Melbourne, Australia

Shaun O’Connor is the Senior Oncology pharmacist at Eastern Health in Melbourne, Australia. He has served on the ISOPP Secretariat as a general member for the past 3 years, and was a leader on the ISOPP website redesign task force. He was on the Organising Committee for the ISOPP International Symposium in 2012 as well as the ISOPP Regional Symposia in 2011, 2013 and 2015, which were all held in Melbourne. He has professional interests in malignant haematology and workflow redesign, and social interests in Aikido and tennis. 

Back to Top

Pablo Ramirez, Catholic University, Santiago, Chile

Pablo Ramirez, MD completed a Hematology Oncology Fellowship at Catholic University in Santiago in 2004 followed by a Malignant Hematology Fellowship at Washington University in St Louis in 2009 and an Advanced Training Program in Hematopoietic Cell Transplantation at the University of Minnesota in Minneapolis in 2010. Currently he is an Assistant Professor at the Hematology Oncology Department at Catholic University. He has published articles in Blood, BBMT, BMT and RBHH among others. He is a member of ASH, ASBMT, SOCHIHEM and Sociedad Chilena de Trasplante. He participates as a member of EUNACOM and the Comisión Nacional de Acreditación.

Juan Roldán Saelzer, Instituto de Salud Pública de Chile, Santiago, Chile